Genomictree Inc.
228760
Rang în acțiuni
#19187
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Preț acțiune
$6.58
Capitalizare de piață
$161.41M
Schimbare (1 zi)
-0.63%
Schimbare (1 an)
-50.29%
Țară
KR
Tranzacționează Genomictree Inc. (228760)
Categorie
Healthcare
Istoricul spliturilor pentru Genomictree Inc. (228760)
Acțiunea Genomictree Inc. (simbol: 228760) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 21, 2026.
O acțiune 228760 cumpărată înainte de Oct 21, 2026 este echivalentă astăzi cu 0 acțiuni 228760.
Cel mai recent split a avut loc pe Oct 21, 2026.
O acțiune 228760 cumpărată înainte de Oct 21, 2026 este echivalentă astăzi cu 0 acțiuni 228760.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | |||
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|